Cryptic diversity in intestinal protists. by Clark, CG
Ali, IK; Hossain, MB; Roy, S; Ayeh-Kumi, PF; Petri, W. A., Jr;
Haque, R; Clark, CG (2003) Entamoeba moshkovskii infections in
children, Bangladesh. Emerging infectious diseases, 9 (5). pp. 580-4.
ISSN 1080-6040
Downloaded from: http://researchonline.lshtm.ac.uk/17191/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial No Derivatives
http://creativecommons.org/licenses/by-nc-nd/2.5/
Entamoeba moshkovskii cysts are morphologically
indistinguishable from those of the disease-causing
species E. histolytica and the nonpathogenic E. dispar.
Although sporadic cases of human infection with E.
moshkovskii have been reported, the organism is consid-
ered primarily a free-living amoeba. No simple molecular
detection tool is available for diagnosing E. moshkovskii
infections. We used polymerase chain reaction (PCR) to
detect E. moshkovskii directly in stool. We tested 109 stool
specimens from preschool children in Bangladesh by PCR;
17 were positive for E. histolytica (15.6%) and 39 were pos-
itive for E. dispar (35.8%). In addition, we found that 23
(21.1%) were positive for E. moshkovskii infection, and 17
(73.9%) of these also carried E. histolytica or E. dispar. The
high association of E. moshkovskii with E. histolytica and E.
dispar may have obscured its identification in previous
studies. The high prevalence found in this study suggests
that humans may be a true host for this amoeba. 
Entamoeba moshkovskii, considered to be primarily afree-living amoeba, is indistinguishable in its cyst and
trophozoite forms from E. histolytica (the cause of inva-
sive amebiasis) and E. dispar (a common noninvasive par-
asite), except in cases of invasive disease when E. histolyt-
ica trophozoites may contain ingested red blood cells. E.
moshkovskii has so far rarely been shown to infect humans;
however, the organism appears to be ubiquitous in anoxic
sediments. Although the early isolations of this species
were from sewage, E. moshkovskii can also be found in
environments ranging from clean riverine sediments to
brackish coastal pools (1). E. moshkovskii is osmotolerant,
can be cultured at room temperature, and is resistant to
emetine, all characteristics that distinguish it from E. his-
tolytica and E. dispar (2–5). Human isolates of E.
moshkovskii to date have come from North America, Italy,
South Africa, and Bangladesh, and they have never been
associated with disease (5,6). However, few studies have
actually set out to identify such infections (7).
The structural resemblance of the apparently innocuous
E. moshkovskii to the disease-causing E. histolytica makes
differentiating the two species important. In the clinical
setting, for example, an E. moshkovskii–infected patient
could be diagnosed as infected with E. histolytica and be
treated unnecessarily with antiamebic chemotherapy. Most
studies that have investigated the prevalence of E. histolyt-
ica and E. dispar have not considered the possible pres-
ence of E. moshkovskii, partly because of a lack of tools to
detect E. moshkovskii other than cultivation, which is
labor-intensive, not always successful, and problematic in
the case of mixed infections. We report for the first time
the application of tools to detect the species directly in
stool and investigate the prevalence of E. moshkovskii in
humans, a group of children in an E. histolytica– and E.
dispar–endemic area where the first human infection with
E. moshkovskii from Bangladesh was detected (6). 
Materials and Methods
Stool Specimens
Fecal specimens included in this study were from 109
preschool children ages 2–5 years from Mirpur, an urban
slum in Dhaka, Bangladesh. Based on results of poly-
merase chain reaction (PCR) on stool DNA samples, 39
were E. dispar–positive, 17 were E. histolytica–positive,
and 1 was positive for both E. histolytica and E. dispar. Of
the 52 samples negative by stool PCR, 18 were eventually
found positive for E. histolytica, E. dispar, or both, either
by PCR from culture DNA or by antigen detection tests
performed on stool specimens, and the remaining 34 sam-
ples were negative by all methods. Only four of the sam-
ples were from children with diarrhea. 
Cell Culture and Isoenzyme Analysis
All stool samples were cultured for Entamoeba species
in Robinson’s medium (8) within 6 hours of collection, and
hexokinase isoenzyme analysis was performed when pos-
sible as previously described (9). E. moshkovskii strains
Laredo and FIC were maintained axenically in LYI-S-2
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medium (10) with 10% adult bovine serum. Laredo (ATCC
30042) is a human isolate, and FIC (ATCC 30041) is an
environmental isolate. E. histolytica HM-1:IMSS clone 9
(ATCC 50528) and E. dispar SAW760 (ATCC 50484)
were used as controls.
Antigen Detection Tests for E. histolytica and E. dispar
The TECHLAB, Inc. (Blacksburg, VA) Entamoeba test
(designed to detect but not differentiate E. histolytica and
E. dispar antigen in stool specimens) and E. histolytica test
(designed to detect specifically E. histolytica in stool spec-
imens) were performed on stool specimens according to
the manufacturer’s instructions (9). 
Preparation of DNA
Stool DNA was isolated by using a modified version of
the silica-DNA binding method of Katzwinkel-Wladarsch
et al. as previously described (11,12). Culture DNA was
isolated by a cetyltrimethylammonium bromide (CTAB)
extraction method as previously described (13), dissolved
in 10 mM Tris-Cl (pH 8.5), and passed over a Microspin S-
200 HR column (Amersham Biosciences UK Ltd,
Chalfont St. Giles, England). RNA was removed by the
addition of RNase A (Promega UK, Ltd, Southampton,
England) to 0.05 µg mL-1.
Small Subunit rRNA Gene Amplification
Based on the sequences of the small subunit rRNA
genes (SSU-rDNA) of E. histolytica and E. dispar, nested
sets of primers (designated E-1/E-2, Eh-1/Eh-2, and Ed-
1/Ed-2) were used, as described (11), to detect E. histolyt-
ica and E. dispar in stool specimens (Table 1). Based on
the sequence of the SSU-rDNA gene of E. moshkovskii
Laredo (GenBank accession no. AF 149906), a nested set
of primers (designated Em-1/Em-2 and nEm-1/nEm-2)
was designed (unpub. data) and used to detect E.
moshkovskii in stool DNA (Table 1). In the initial PCR
(total vol. 25 µL), 1.0 µL of stool or culture DNA was
used. Thermal cycler conditions included 30 cycles, each
consisting of 92°C for 1 min, 55°C for 1 min, and 72°C for
1 min, followed by a final extension of 7 min at 72°C. In
the nested PCR, 1.0 µL of first PCR product was used as
the template DNA and the annealing temperature was
raised to 62°C, leaving the other parameters of the ampli-
fication cycles unchanged. E. moshkovskii–specific nested
SSU-rDNA gene amplification products were digested
with restriction endonuclease XhoI for 1 h at 37°C accord-
ing to the manufacturer’s instructions (Invitrogen Corp.,
Carlsbad, CA) to verify species identity. All PCR products
were separated in 1.8% NuSieve 3:1 agarose gels
(Flowgen, Lichfield, England) in 1x Tris-borate-EDTA
buffer and visualized after staining with ethidium bromide
(0.2 µg mL-1; Sigma-Aldrich Co. Ltd, Poole, England).
ArgTCT Gene PCR Amplification
Based on the sequence of the ArgTCT tRNA gene of E.
histolytica, a set of primers were designed (ArgTCT-1 and
ArgTCT-2). Thermal cycler conditions for PCR were the fol-
lowing: 30 cycles each, consisting of 94°C for 1 min, 55°C
for 1 min 30 s, and 72°C for 2 min, followed by a final
extension of 5 min at 72°C. The ArgTCT amplification prod-
ucts from E. moshkovskii Laredo, E. moshkovskii MS15-
3646 (one of the infections detected above), and E. dispar
SAW760 were cloned into the pGEM-T Easy vector
(Promega) and sequenced (MWG Biotech Ltd, Milton
Keynes, England). From the sequence results, an E.
moshkovskii–specific primer pair, EmR-1 and EmR-2, was
designed to amplify the E. moshkovskii ArgTCT gene frag-
ment specifically (Table 1). PCR amplification was per-
formed at an annealing temperature of 58°C as described
for ArgTCT gene amplification. 
Results
Culture and Isoenzyme Analysis 
All 109 stool specimens were added to Robinson’s
medium for growth of Entamoeba species. Incubation led
to growth of E. histolytica/E. dispar/E. moshkovskii in 33
cultures and E. coli in 8 cultures (no growth of E. hartman-
ni or Endolimax nana was observed). Hexokinase isoen-
zyme analysis was possible for 10 cultures; 4 of them
showed the band pattern of Entamoeba histolytica, 5
showed E. dispar, and 1 showed the band pattern of E. dis-
par with an extra band just behind the faster moving band,
perhaps indicating a mixed culture with E. moshkovskii.
Detection of E. moshkovskii by Nested PCR
The reference strain E. moshkovskii Laredo gave the
expected band at approximately 260 bp with the E.
moshkovskii–specific SSU-rDNA nested primers, whereas
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Table 1. Oligonucleotide primers used to detect Entamoeba 
histolytica, E. moshkovskii, and E. dispar in stool specimens 
Primer Primer sequence (5´ to 3´) 
E-1 TTT GTA TTA GTA CAA A 
E-2 GTA [A/G]TA TTG ATA TAC T 
Eh-1 AAT GGC CAA TTC ATT CAA TG 
Eh-2 TTT AGA AAC AAT GCT TCT CT 
Ed-1 AGT GGC CAA TTT ATG TAA GT 
Ed-2 TTT AGA AAC AAT GTT TCT TC 
Em-1 CTC TTC ACG GGG AGT GCG 
Em-2 TCG TTA GTT TCA TTA CCT 
nEm-1 GAA TAA GGA TGG TAT GAC 
nEm-2 AAG TGG AGT TAA CCA CCT 
ArgTCT-1 AGC ATC AGC CTT CTA AGC TG 
ArgTCT-2 CTT CCG ACT GAG CTA ACA AG 
EmR-1 GGC GCC TTT TTT ACT TTA TGG 
EmR-2 GCT AAC AAG GCC AAT CGA TAA A 
 
control E. histolytica HM-1:IMSS and E. dispar SAW760
DNAs were negative. Twenty-three of 109 (21%) stool
DNA samples were positive by nested PCR for E.
moshkovskii (Table 2). Of these, seven were positive for
amoebae by culture; one DNA sample extracted from these
cultures was positive for E. moshkovskii. Seventeen of the
23 E. moshkovskii–positive samples were also positive for
E. histolytica, E. dispar, or both, by either PCR of stool
SSU rDNA (13/17) or by TECHLAB Entamoeba or E. his-
tolytica tests (15/17) (Figure 1). One of the four children
with diarrhea was positive for E. moshkovskii and coinfect-
ed with E. dispar. The cause of his diarrhea remained
undetermined. 
A comparison of SSU-rDNA sequences from E.
moshkovskii, E. histolytica, and E. dispar, showed that the
restriction endonuclease XhoI cuts exclusively in the E.
moshkovskii–specific, 258-bp–nested PCR product to pro-
duce 236-bp and 22-bp fragments. Products from all 23
positive stool samples and the Laredo strain showed the
presence of this site (Figure 1).
ArgTCT PCR and Sequence Analysis
To detect polymorphism among the E. moshkovskii
samples, we studied a locus known to show polymorphism
in E. histolytica and E. dispar (unpub. data). The ArgTCT
primers amplify E. histolytica, E. dispar, and E.
moshkovskii DNA. The sizes of the PCR products from E.
histolytica HM-1:IMSS, E. dispar SAW760, and E.
moshkovskii Laredo were 586 bp, 586 bp, and 323 bp,
respectively. We did not observe a band in the 250- to 350-
bp region in any of the E. histolytica and E. dispar strains
with these primers (data not shown). Because 17 of 23 E.
moshkovskii–positive samples were also positive for E.
histolytica, E. dispar (by SSU-rDNA PCR or TECHLAB
enzyme-linked immunosorbent assay), or both, we ignored
products in the 500- to 600-bp region (assuming that they
were derived from E. histolytica or E. dispar DNA) and
considered a sample positive for E. moshkovskii when it
produced a band at approximately 300 bp. By this criteri-
on, we found 18 of 23 samples were positive for E.
moshkovskii, and they showed slight PCR product size
variation (data not shown). The PCR products from one
stool sample, E. moshkovskii Laredo and E. dispar
SAW760, were cloned, sequenced, and aligned with that of
E. histolytica HM-1:IMSS, and E. moshkovskii–specific
primers (EmR-1 and EmR-2) were designed (Figure 2). In
addition to notable PCR product size differences, analysis
clearly showed that the E. moshkovskii sequence is com-
pletely different from those of E. histolytica and E. dispar
and, unlike the E. histolytica and E. dispar sequences, it
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Table 2. Nested SSU rDNA polymerase chain reaction (PCR) 
(for Entamoeba histolytica, E. dispar, or both) and stool antigen-
detection test results of the 17 E. moshkovskii–positive 
samplesa 
SSU rRNA gene PCR for  
E. histolytica/E. dispar 
Samples 
Stool antigen-
detection test 
results Stool DNA Culture DNA 
1b E. histolytica E. dispar Mixed 
2 E. dispar 0 NC 
3 E. dispar E. dispar NC 
4 E. histolytica 0 NC 
5 E. dispar E. dispar E. dispar 
6b E. dispar Mixed E. dispar 
7 E. dispar E. dispar NC 
8 E. dispar E. dispar NC 
9 E. dispar E. dispar NC 
10 0 E. dispar NC 
11 E. dispar E. dispar NC 
12 E. dispar 0 NC 
13c E. dispar E. histolytica NC 
14 0 0 E. dispar 
15 E. dispar 0 E. dispar 
16 0 0 E. dispar 
17 E. histolytica 0 NC 
18 0 0 NC 
19 0 0 NC 
20 0 0 NC 
21 0 0 NC 
22 0 0 NC 
23 0 0 NC 
aNC, no culture; 0, negative. All stool antigen tests that are positive for E. 
histolytica can also be mixed because no specific E. dispar antigen test exists. 
bPatients 1 and 6 likely had mixed infections with E. histolytica and E. dispar, in 
which E. histolytica was much lower in number than E. dispar in the stool 
specimen. For patient 1, SSU rDNA PCR failed to detect E. histolytica, though 
both species grew in the culture. For patient 6, although SSU rDNA PCR could 
detect E. histolytica in stool DNA, the E. histolytica antigen-detection test failed 
to detect E. histolytica, and only E. dispar survived in the culture. 
cThe stool specimen of patient 13 was marginally negative by the E. histolytica 
antigen-detection test (optical density value was 0.13 where the cut-off value for 
a positive result was 0.15). 
Figure 1. Entamoeba moshkovskii–specific nested SSU rDNA
polymerase chain reaction (PCR) products. Odd- and even-num-
bered lanes represent undigested and XhoI-digested PCR prod-
ucts, respectively. Lanes 1/2, E. moshkovskii Laredo; lanes
3/4–5/6, DNA from stool samples. M, a 50-bp DNA ladder
(Invitrogen Corp.).
350bp
200bp
contains no short tandem repeat sequences (Figure 2C). 
The EmR primers amplified the expected 265-bp frag-
ment from E. moshkovskii Laredo DNA and did not ampli-
fy E. histolytica HM-1:IMSS or E. dispar SAW760 DNA.
However, they successfully amplified 10 of a possible 23
E. moshkovskii–positive stool DNA samples. The most
likely reason why these primers did not amplify the other
13 E. moshkovskii DNA samples is that they differed in
sequence in the primer-binding regions. Although the PCR
product size of the 10 positive samples was slightly differ-
ent from that of Laredo, they were very similar in size to
each other (Figure 3). The DNA of the previously reported
E. moshkovskii ICDDRB:717, isolated from humans in the
same geographic location (6), also gave a product of the
same size (Figure 3, lane 2). The EmR primers successful-
ly amplified DNA from environmental E. moshkovskii iso-
late FIC, but its product size was quite different from that
of the human isolates of E. moshkovskii (Figure 3, lane 7).
Discussion
The main objectives of this study were to develop
molecular tools to identify E. moshkovskii and to investi-
gate its prevalence and diversity in humans. We were suc-
cessful in developing a simple diagnostic technique: a
nested SSU-rDNA PCR followed by restriction endonucle-
ase digestion. We chose to use nested PCR to detect E.
moshkovskii infections because our previous experience in
this area showed that nested PCR was much more efficient
in amplifying stool DNA (14). Our attempt to produce a
species-specific polymorphic marker was not completely
successful. The EmR primers failed to amplify 13 of 23 E.
moshkovskii–containing samples, probably because of
sequence differences in primer-binding sites. However, the
ArgTCT primers, originally designed to amplify E. histolyti-
ca and E. dispar DNA, did amplify most of the E.
moshkovskii samples, producing a product distinct in size
from those of E. histolytica and E. dispar. 
Our study has some limitations. The subjects were chil-
dren 2–5 years of age, so we do not know whether these
subjects are representive of all age groups. All previous
human isolates of E. moshkovskii have belonged to
ribodeme 2 (5). Our attempts to perform riboprinting on
these infections were unsuccessful, likely because of the
size of the amplification target (approximately 1.95 kb).
Even if PCR had been successful, the presence of mixed
infections with other eukaryotes would have prevented
successful typing. 
This study has several important findings. The overall
E. moshkovskii prevalence (21%) suggests that this infec-
tion is common among these children. E. dispar–infected
children were almost twice as likely to have a mixed infec-
tion with E. moshkovskii (35%) compared to those with
(18%) or without E. histolytica (18%) infections. None of
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Figure 2. ArgTCT locus. ArgTCT sequences from Entamoeba histolyt-
ica HM-1:IMSS (GenBank accession no. AZ535059), E. dispar
SAW760 (GenBank accession no. AF 525284), E. moshkovskii
Laredo (GenBank accession no. AF 525285), and MS15-3646
(GenBank accession no. AF525286) were aligned at the 5´(A) and
3´ (B) ends to design E. moshkovskii–specific primers. The EmR
primer sequences are shown in italic and bold with E.
moshkovskii–specific positions underlined. C. Schematic repre-
sentation of ArgTCT loci from E. histolytica HM-1:IMSS, E. dispar
SAW760, and E. moshkovskii. Locations of the primers used in
polymerase chain reaction amplification are indicated by small
arrows, the tRNA genes are indicated by large arrows, and the
short tandem repeats by shaded boxes (not to scale.)
the six children with E. moshkovskii monoinfections had
diarrhea or dysentery, which suggests that E. moshkovskii
is a noninvasive parasite. The high prevalence of E.
moshkovskii infection may have been unnoticed over the
years because most such infections (74%) were mixed
infections with E. histolytica, E. dispar, or both. Previous
attempts to identify human E. moshkovskii infections (7)
may have failed because the human intestinal flora was
unsuitable for cultivation at room temperature.
The high prevalence of E. moshkovskii shown in this
study population indicates that perhaps humans are a true
host for this putatively free-living amoeba and are not just
transiently infected. This prevalence may also explain
some of the microscopy-positive/antigen-negative results
obtained when using the Entamoeba test kit (15).
Epidemiologic studies of E. histolytica infection should
include tools to diagnose all three of these species individ-
ually, simultaneously, and accurately, and the prevalence
of E. moshkovskii infection in other regions of the world
should be investigated.
Acknowledgments
The International Centre for Diarrheal Disease Research,
Dhaka, Bangladesh, acknowledges with gratitude the commit-
ment of University of Virginia to the Centre’s research efforts. Mr.
Ali is funded by the Commonwealth Scholarship Commission.
This research was supported in part by a grant received by
International Centre for Diarrheal Disease Research, Dhaka,
Bangladesh, Centre for Health and Population Research, with the
support of University of Virginia (NIH grant AI-43596) and by
grant 067314 from the Wellcome Trust awarded to C.G. Clark. 
Mr. Ali is a senior research officer at the International Centre
for Diarrheal Disease Research, Dhaka, Bangladesh, on leave and
studying for his doctorate in the Department of Infectious and
Tropical Diseases, London School of Hygiene and Tropical
Medicine. His current research focus includes genetic diversity in
Entamoeba species. 
References
1. Clark CG, Diamond LS. Intraspecific variation and phylogenetic rela-
tionships in the genus Entamoeba as revealed by riboprinting. J Euk
Microbiol 1997;44:142–54.
2. Dreyer DA. Growth of a strain of Entamoeba histolytica at room tem-
perature. Tex Rep Biol Med 1961;19:393–6.
3. Entner N, Most H. Genetics of Entamoeba: characterization of two
new parasitic strains that grow at room temperature (and at 37°C). J
Protozool 1965;12:10–3.
4. Richards CS, Goldman M, Cannon LT. Cultivation of Entamoeba his-
tolytica and Entamoeba histolytica-like strains at reduced tempera-
ture and behavior of the amoebae in diluted media. Am J Trop Med
Hyg 1966;5:648–55.
5. Clark CG, Diamond LS. The Laredo strain and other Entamoeba his-
tolytica–like amoebae are Entamoeba moshkovskii. Mol Biochem
Parasitol 1991;46:11–8.
6. Haque R, Ali IKM, Clark CG, Petri WA Jr. A case report of
Entamoeba moshkovskii infection in a Bangladeshi child. Parasitol
Int 1998;47:201–2.
7. Robinson GL, Sargeaunt PG. Low temperature strains of Entamoeba
histolytica. Trans R Soc Trop Med Hyg 1969;63:412–3.
8. Robinson GL. The laboratory diagnosis of human parasitic amoebae.
Trans R Soc Trop Med Hyg 1968;62:285–94.
9. Haque R, Kress K, Wood S, Jackson TFHG, Lyerly D, Wilkins T, et
al. Diagnosis of pathogenic Entamoeba histolytica infection using a
stool ELISA based on monoclonal antibodies to the galactose-specif-
ic adhesin. J Infect Dis 1993;167:247–9.
10. Clark CG, Diamond LS. Methods for cultivation of luminal parasitic
protists of clinical importance. Clin Microbiol Rev 2002;15:329–41.
11. Haque R, Ali IKM, Akther S, Petri WA Jr. Comparison of PCR, isoen-
zyme analysis, and antigen detection for diagnosis of Entamoeba his-
tolytica infection. J Clin Microbiol 1998;36:449–52.
12. Katzwinkel-Wladarsch S, Löscher T, Rinder H. Direct amplification
and differentiation of pathogenic and nonpathogenic Entamoeba his-
tolytica DNA from stool specimens. Am J Trop Med Hyg
1994;51:115–8.
13. Clark CG, Diamond LS. Entamoeba histolytica: a method for isolate
identification. Exp Parasitol 1993;7:450–5.
14. Ayeh-Kumi PF, Ali IKM, Lockhart LA, Gilchrist CA, Petri WA Jr,
Haque R. Entamoeba histolytica: genetic diversity of clinical isolates
from Bangladesh as demonstrated by polymorphisms in the serine-
rich gene. Exp Parasitol 2001;99:80–8.
15. Haque R, Neville LM, Hahn P, Petri WA Jr. Rapid diagnosis of
Entamoeba infection by using Entamoeba and Entamoeba histolytica
stool antigen detection kits. J Clin Microbiol 1995;33:2558–61.
Address for correspondence: C. Graham Clark, Department of Infectious
and Tropical Diseases, London School of Hygiene and Tropical
Medicine, Keppel Street, London, WC1E 7HT, England; fax: +44-207-
636-8739; email: graham.clark@lshtm.ac.uk
584 Emerging Infectious Diseases • Vol. 9, No. 5, May 2003
RESEARCH
Figure 3. EmR polymerase chain reaction products. Lane 1,
Entamoeba moshkovskii Laredo; lane 2, E. moshkovskii ICD-
DRB:717; lanes 3–6, E. moshkovskii–positive stool DNA samples;
lane 7, E. moshkovskii FIC; lane 8, E. histolytica HM-1:IMSS; and
lane 9, E. dispar SAW760. M, a 100-bp DNA ladder (Promega).
